Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial

  • Yong Zhao1, 2Email author,
  • Zhaoshun Jiang3,
  • Tingbao Zhao4,
  • Mingliang Ye5,
  • Chengjin Hu6,
  • Huimin Zhou7,
  • Zhaohui Yin3,
  • Yana Chen8,
  • Ye Zhang2,
  • Shanfeng Wang2,
  • Jie Shen2,
  • Hatim Thaker1,
  • Summit Jain1,
  • Yunxiang Li2,
  • Yalin Diao5,
  • Yingjian Chen6,
  • Xiaoming Sun6,
  • Mary Beth Fisk9 and
  • Heng Li10
BMC Medicine201311:160

DOI: 10.1186/1741-7015-11-160

Received: 15 February 2013

Accepted: 30 May 2013

Published: 9 July 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
15 Feb 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
21 Feb 2013 Author responded Author comments - Yong Zhao
Resubmission - Version 3
21 Feb 2013 Submitted Manuscript version 3
4 Mar 2013 Reviewed Reviewer Report - Sigurd Lenzen
5 Apr 2013 Reviewed Reviewer Report - Anne Joerns
26 Apr 2013 Author responded Author comments - Yong Zhao
Resubmission - Version 4
26 Apr 2013 Submitted Manuscript version 4
16 May 2013 Reviewed Reviewer Report - Anne Joerns
17 May 2013 Reviewed Reviewer Report - Sigurd Lenzen
25 May 2013 Author responded Author comments - Yong Zhao
Resubmission - Version 5
25 May 2013 Submitted Manuscript version 5
Publishing
30 May 2013 Editorially accepted
9 Jul 2013 Article published 10.1186/1741-7015-11-160

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago
(2)
Tianhe Stem Cell Biotechnologies Inc.
(3)
Section of Endocrinology, General Hospital of Jinan Military Command
(4)
Stem Cell Treatment Center, General Hospital of Jinan Military Command
(5)
Section of Blood Transfusion, General Hospital of Jinan Military Command
(6)
Section of Molecular Diagnostics, General Hospital of Jinan Military Command
(7)
Section of Endocrinology, The First Hospital of Hebei Medical University
(8)
Department of Obstetrics, Jinan Central Hospital, Shandong University
(9)
Texas Cord Blood Bank
(10)
Department of Neurology, Jinan Central Hospital, Shandong University

Advertisement